Upgrade to SI Premium - Free Trial

Marvell (MRVL) PT Lowered to $52 at UBS Despite Guidaing Ahead of Consensus

March 4, 2021 6:07 AM
UBS analyst Timothy Arcuri lowered the price target on Marvell (NASDAQ: MRVL) to $52.00 (from $53.00) after guidance exceeded sell-side ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles